The world’s first FDA-cleared, computer-based platform designed expressly for primary-care physicians to measure and monitor brain health to detect the early signs of dementia.
Cognivue® Cognitive Assessment Tool Receives FDA Clearance
Cerebral Assessment Systems is excited to announce that it has received FDA clearance for its revolutionary Cognivue® cognitive assessment system—a first-of-its-kind, computer-based tool designed to better and more easily assess, measure, and monitor brain function to detect early signs of dementia.
In fact, Cognivue is so unique that it led the FDA to create an entirely new class of devices, designated “Cognitive Assessment Aids” (FDA Category: 882.1470). This clearance allows Cerebral Assessment Systems to begin production and marketing of Cognivue.